Prashanth Fertility launched 'Prashanth Fertility at Home' on Wednesday, September 2, 2026, at a press conference in Chennai, introducing a dedicated service offering home-based support for eligible In-Vitro Fertilization related treatments across the city. According to Prashanth Group of Hospitals, the primary goal of the new offering is to help couples maintain continuity throughout their assisted reproduction cycles by bringing specialized fertility-care services directly to residential locations.
Launch Event and Leadership Remarks
The official launch event on September 2, 2026, was attended by Dr. Geetha Haripriya, Chairperson of Prashanth Group of Hospitals, Parthipan J, CEO of Prashanth Fertility, and Dr. Samhitha Moturi, Director of Prashanth Group of Hospitals. Actor Khushbu Sundar participated as the chief guest for the rollout.
Speaking at the press conference, Dr. Geetha Haripriya stated that the initiative is aimed not merely at convenience but at ensuring continuity, confidence, and compassionate care for patients. Dr. Samhitha Moturi added that fertility treatment involves multiple appointments, medication schedules, and monitoring, which can be challenging for couples balancing work and family responsibilities. According to Dr. Samhitha Moturi, this service helps reduce such disruptions.
Chief guest Khushbu Sundar emphasized that making fertility treatment simpler and more accessible could provide greater comfort and confidence to couples undergoing an emotionally demanding journey, noting that pregnancy is not a woman's job alone and that professional home care allows working couples and women to pursue their personal and professional goals without interruption.
Operational Mechanics and Service Delivery
Per the announcement by Prashanth Fertility, a dedicated team and vehicle will travel across Chennai to deliver services including injection support, eligible monitoring, follow-ups, and treatment coordination. Patients can schedule these services through a dedicated digital interface on the Prashanth Fertility app, which facilitates the management of appointments, follow-ups, and medical records to maintain a continuous connection with fertility specialists.
According to institutional data, Prashanth Fertility Research Centre was founded in 2001 and is recognized as a leader in Reproductive Medicine and Assisted Reproductive Technologies in India. Dr. Geetha Haripriya possesses over 40 years of experience in the field and has helped over 45,000 couples achieve parenthood through assisted reproductive technologies. Additionally, Prashanth Fertility has established a 24x7 helpline, 044-2888-2888, to provide service details and eligibility information. Institutional representatives claim that 80% of IVF treatment can be conducted at home through this service.
Verification Gaps and Clinical Oversight
While the clinic detailed the operational framework, the specific financial investment made by Prashanth Fertility for the launch of these home-based services was not publicly disclosed. Furthermore, the exact number of dedicated teams and vehicles deployed for the service was not specified in the official briefing, and no specific success rate or projected impact metrics for the home-based service were provided at the time of launch.
While direct opposing perspectives or criticisms specifically targeting Prashanth Fertility's home-based IVF support services were absent from available coverage, broader medical discussions around home-based health interventions frequently note potential concerns regarding the maintenance of clinical oversight for complex procedures, data privacy protocols for medical records, and the consistent training standards of deployed home-care staff.
Comparative Context and Downstream Stakes
While many fertility clinics offer initial teleconsultations or at-home testing kits, a comprehensive home-based IVF support service that includes physical visits for injection support, eligible monitoring, and treatment coordination via a dedicated team and vehicle represents a notable advancement in India. Prashanth Fertility has described the program as a first-of-its-kind initiative in Chennai, differing from global models where at-home offerings typically remain restricted to preliminary diagnostics or virtual consultations.
Couples in Chennai undergoing IVF treatment, particularly working couples, constitute the primary stakeholder group affected by the rollout. Per the institutional design, these patients will benefit from increased convenience and treatment continuity as eligible services like injections and monitoring arrive at home, reducing the necessity for frequent physical visits to the fertility centre. This operational shift is intended to alleviate the logistical and emotional burdens associated with balancing professional and personal responsibilities during fertility treatment, ultimately aiming to minimize treatment disruptions and improve adherence to prescribed medical protocols.
